SHANGHAI, May 10, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract presentation on SKG1108, its investigational...
Read More Details
Finally We wish PressBee provided you with enough information of ( Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 )
Also on site :
- Anne Burrell's Memorial Included 'Big Send-Off' of Billy Joel Karaoke With Food Network Colleagues
- Planting the seeds for remembering
- NYT Mini Crossword Answers, Hints for Saturday, June 21, 2025